Vertex Pharmaceuticals Incorporated VRTX
$ 499.87
5.72%
Quarterly report 2024-Q2
added 08-02-2024
Vertex Pharmaceuticals Incorporated Depreciation & Amortization 2011-2024 | VRTX
Annual Depreciation & Amortization Vertex Pharmaceuticals Incorporated
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
181 M | 148 M | 126 M | 110 M | 107 M | 72.4 M | 61.4 M | 61.4 M | 62.3 M | 63.3 M | 48.4 M | 38.2 M | 35 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
181 M | 35 M | 85.7 M |
Quarterly Depreciation & Amortization Vertex Pharmaceuticals Incorporated
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 53.5 M | - | - | - | 38.8 M | - | 110 M | - | 35.9 M | - | 91.8 M | - | 28.8 M | - | 80.2 M | 53.5 M | 26.8 M | - | 80.7 M | 54.8 M | 27.1 M | - | 53.6 M | 34.4 M | 16.3 M | - | 45 M | 29.7 M | 14.8 M | - | 45.9 M | 31.4 M | 16.4 M | - | 46.6 M | 30.4 M | 16.4 M | - | 46.9 M | 30 M | 15.8 M | - | 30.7 M | 21.2 M | 10.7 M | - | 25.8 M | 17.2 M | 8.56 M | - | 25.3 M | 17.6 M | 8.86 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
110 M | 8.56 M | 36.7 M |